CDK-IN-18

CAT: 0804-HY-201330Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-201330Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK-IN-18 (Compound EX.161) is an orally active, brain-penetrant and selective inhibitor of CDK2, CDK4, and CDK6. CDK-IN-18 inhibits the activity of cyclin-CDK complexes, blocks phosphorylation of the retinoblastoma protein (pRb), arresting the cell cycle transition from G1 to S phase. CDK-IN-18 is promising for research of cancers, such as breast cancer (especially hormone receptor-positive, HER2-negative type), lung cancer, and colorectal cancer[1][2].
CAS Number
[2531743-46-9]
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
CC(C1=C2N(N=C1)C=CC(C3=NC(NC4=CC=C(N5C(C[C@H](CC5)N(C)C)=O)C=N4)=NC=C3)=C2)C
Molecular Formula
C26H30N8O
Molecular Weight
470.57
References & Citations
[1]Zhilong Hu, et al. Cdk inhibitors. WO2020224568A1. 2020-11-12.|[2]Xiaotian Zhu, et al. Salt and solid forms of a cdk inhibitor. WO2025103447A1. 2025-05-22.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK4; CDK6

Related Products

CatalogName
HY-13033-01CDK-IN-2
HY-150641-01CDK-IN-9
HY-168067CDK-IN-14
HY-147386-01CDK-IN-10
HY-170507CDK-IN-16
HY-149173-01CDK-IN-11
HY-169245-01CDK-TCIP2
HY-169244-01CDK-TCIP1
HY-157297CDK-IN-13
HY-168134CDK-IN-15

Alternative Products

CatalogName
T211060-01CDK-IN-18
M35483-01CDK-IN-10
T36741-01CDK-IN-6
T75127-01CDK-IN-12
T201193-01CDK-IN-15
T204162-01CDK-IN-16
MBS5804923CDK-IN-9
BUP12701-01CDK-IN-2
T201211-01CDK-TCIP2
T84917-01CDK-IN-11

Popular Products